 NEW YORK, March 10, 2021 PRNewswire -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI LSE: RENX NASDAQ: RNLX, announced today it has been named to Fast Companys prestigious annual list of the Worlds Most Innovative Companies for 2021 and ranked first in the Joint Ventures category. Kantaro launched in May 2020 in response to the COVID-19 pandemic to make a high-performing SARS-CoV-2 IgG antibody test created at Mount Sinai broadly accessible worldwide. 